Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Part of paid clinical trials in Manchester, Connecticut.
- Sponsor
- i-Lumen Scientific AUS PTY LTD
- Study ID
- NCT06662162
- Status
- Recruiting
Conditions
- Age-Related Macular Degeneration
- Age-related Macular Degeneration (ARMD)
- Geographic Atrophy Secondary to Age-related Macular Degeneration
- Intermediate AMD
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- i-Lumen AMD — DEVICEi-Lumen AMD transpalpebral microcurrent stimulation system
Study Details
The goal of this clinical trial is to characterize the safety and effectiveness of the i-Lumen AMD transpalpebral microcurrent device and therapy in patients with intermediate to advanced nonexudative AMD. Participants will: * Undergo an initial loading regimen, followed by 7 maintenance over the course of 11 months. * Participants will return monthly through Month 14 (3 months post-last treatment) for evaluation and monitoring.
Key Dates
- Start date
- May 7, 2025
- Status verified
- Apr 2026
- Primary completion
- Mar 31, 2027
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Active i-Lumen AMD therapyActive transpalpebral microcurrent therapy
- Sham Comparator: Sham i-Lumen AMD therapySham transpalpebral microcurrent therapy
Primary Outcome Measure
Mean Change BCVA from Baseline [ Time Frame: Month 3 ]
Central Contacts
- Meredith Mundy408-440-7049
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Retina Consultants PC | Manchester | Connecticut | 06042 | Noam Rudnick, MD (PRINCIPAL_INVESTIGATOR) |
| University Retina & Macula Associates | Lemont | Illinois | 60439 | |
| Texas Retina Associates | Fort Worth | Texas | 76104 | Patrick Williams, MD (PRINCIPAL_INVESTIGATOR) |
| Tyler Retina Research Insitute | Tyler | Texas | 75703 | Samuel Minaker, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Manchester, CT
By condition
By specialty
Related Studies
- Stem Cell Ophthalmology Treatment Study IIRecruiting · MD Stem Cells · Westport, Connecticut
- A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular DegenerationPHASE1 · Recruiting · Astellas Institute for Regenerative Medicine · Phoenix, Arizona
- Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMDRecruiting · VisionCare, Inc. · Loma Linda, California
- Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular DegenerationPHASE1/PHASE2 · Recruiting · Perceive Biotherapeutics, Inc. · Scottsdale, Arizona